/INBS

INBS Stock - Intelligent Bio Solutions Inc.

Q: What is the analyst price target for INBS?

Analyst price target information is not currently available for INBS.

Q: What is INBS's market cap?

Market capitalization information is not currently available for INBS.

Healthcare|Medical - Diagnostics & Research|NASDAQ

$16.67+9.24%

+$1.41 (+9.24%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $18.34

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for INBS

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta4.46

52W High$27.50

52W Low$4.03

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$3.05M	$3.11M	$1.26M	N/A	$1.98M
Gross Profit	$1.25M	$1.43M	$326,668	N/A	$1.98M
Gross Margin	40.8%	45.8%	26.0%	N/A	100.0%
Operating Income	$-10,644,607	$-10,283,174	$-12,595,233	$-8,336,876	$-5,573,482
Net Income	$-10,568,733	$-10,156,759	$-10,631,720	$-8,306,051	$-7,037,286
Net Margin	-346.2%	-326.4%	-845.9%	N/A	-355.3%
EPS	$-20.00	$-63.80	$-105.80	$-113.30	$-162.20

Company Overview

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Visit Website

Earnings History & Surprises

INBS

Beat Rate

47%

Last 15 quarters

Avg Surprise

-77.5%

EPS vs Estimate

Beats / Misses

7/8

Last 12 quarters

Latest EPS

$-3.50

Q4 2025

EPS Surprise History

Q1 24

+36.1%

$-2.07vs$-3.24

Q2 24

-64.4%

$-1.43vs$-0.87

Q3 24

-162.7%

$-1.34vs$-0.51

Q4 24

-32.1%

$-0.70vs$-0.53

Q1 25

+84.4%

$-0.50vs$-3.20

Q2 25

+84.3%

$-0.44vs$-2.80

Q3 25

+69.2%

$-0.37vs$-1.20

Q4 25

-133.3%

$-3.50vs$-1.50

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Feb 12, 2026	—	—	—	—
Q4 2025	Nov 12, 2025	$-1.50	$-3.50	-133.3%	✗ MISS
Q3 2025	Aug 15, 2025	$-1.20	$-0.37	+69.2%	✓ BEAT
Q2 2025	May 13, 2025	$-2.80	$-0.44	+84.3%	✓ BEAT
Q1 2025	Feb 13, 2025	$-3.20	$-0.50	+84.4%	✓ BEAT
Q4 2024	Nov 7, 2024	$-0.53	$-0.70	-32.1%	✗ MISS
Q3 2024	Sep 19, 2024	$-0.51	$-1.34	-162.7%	✗ MISS
Q2 2024	May 8, 2024	$-0.87	$-1.43	-64.4%	✗ MISS
Q1 2024	Feb 9, 2024	$-3.24	$-2.07	+36.1%	✓ BEAT
Q4 2023	Nov 8, 2023	$-7.68	$-12.48	-62.5%	✗ MISS
Q3 2023	Aug 24, 2023	$-19.93	$-22.93	-15.1%	✗ MISS
Q2 2023	May 11, 2023	$-2.07	$-24.37	-1077.3%	✗ MISS
Q1 2023	Feb 14, 2023	$-2.20	$-0.46	+79.1%	✓ BEAT
Q1 2023	Feb 14, 2023	—	$-55.57	—	—
Q4 2022	Nov 9, 2022	$-24.00	$-16.23	+32.4%	✓ BEAT
Q2 2022	May 10, 2022	$-3.20	$-1.80	+43.8%	✓ BEAT
Q1 2022	Feb 10, 2022	$-3.20	$-4.60	-43.7%	✗ MISS
Q4 2021	Nov 12, 2021	—	$-20.46	—	—
Q2 2021	Jun 30, 2021	—	$-12.56	—	—
Q1 2021	Mar 31, 2021	—	$-53.03	—	—

Frequently Asked Questions about INBS

What is INBS's current stock price?

Intelligent Bio Solutions Inc. (INBS) is currently trading at $16.67 per share. The stock has moved +9.24% today.

What is the analyst price target for INBS?

No analyst price targets are currently available for this stock.

What sector is Intelligent Bio Solutions Inc. in?

Intelligent Bio Solutions Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.

What is INBS's market cap?

Intelligent Bio Solutions Inc. has a market capitalization of $0.01 billion, making it a small-cap company.

Does INBS pay dividends?

No, Intelligent Bio Solutions Inc. does not currently pay a dividend to shareholders.